Status:
COMPLETED
Blood Biomarker in Early Parkinson's Disease
Lead Sponsor:
Duke University
Conditions:
Parkinson Disease
Eligibility:
All Genders
50+ years
Brief Summary
Currently, there are no cures or disease modifying therapies for Parkinson's disease (PD). This is partially due to the inability to detect the disease before it has progressed to a stage where there ...
Eligibility Criteria
Inclusion
- Inclusion
- Age matched to PD patient Parkinson's Disease Patients:
- 50 years and older
- PD patient who is seen at the Duke Movement Disorders Center
- Early PD diagnosis (Hoehn and Yahr scale ≤ 3)
- Non-smoking
- No cancer treatment in the last 5 years
- Able to read and speak English
- Healthy Control Participants:
- 50 years and older
- Non-smoking
- No cancer treatment in the last 5 years
- Able to read and speak English
- Exclusion Criteria:
- Parkinson's Disease Patients:
- Known additional neurological disease
- Clinical trial intervention within the last 6 months
- Healthy Control Participants:
- Neurological degenerative diseases (such as Parkinson's, Alzheimer's or Huntington's)
- Clinical trial intervention within the last 6 months
Exclusion
Key Trial Info
Start Date :
January 22 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 7 2019
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT03384797
Start Date
January 22 2018
End Date
January 7 2019
Last Update
June 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Medical Facility
Durham, North Carolina, United States, 27710